The Pharma Data
DECEMBER 28, 2020
Combining next generation sequencing (“NGS”) with its technology platform, the Company performs full-gene sequencing with deletion/duplication analysis in an array of panels that can be tailored to meet specific customer needs.
Drug Discovery World
FEBRUARY 5, 2024
Brian Gladsden, CEO, Mosaic Therapeutics “The industry has already made tremendous strides in targeted drug discovery in oncology, particularly as the industry moves further away from simply looking at tumour histology and relying more on cancer gene sequencing.
Drug Discovery World
MARCH 27, 2023
TREs rely on niche technology that requires highly skilled engineers with comprehensive knowledge of data and compliance—a scarcity in today’s job market. Building foundations for optimal healthcare There’s no doubt TREs can support faster discoveries and better patient outcomes.
Expert insights. Personalized for you.
52 
Let's personalize your content